Diseases [C] » Neoplasms [C04] » Neoplastic Processes
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Neoplastic Processes
Description
The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity. MeSH
Hierarchy View
Subtype Terms (8)
Anaplasia
11 drugs (10 approved, 1 experimental)
Carcinogenesis
5 experimental drugs
Neoplasm Metastasis
737 drugs (313 approved, 424 experimental)
Neoplasm Recurrence, Local
19 drugs (13 approved, 6 experimental)
Neoplasm, Residual
49 drugs (33 approved, 16 experimental)
Phase 2 Indicated Drugs (1)
Phase 1 Indicated Drugs (1)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
